Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 08, 2021

SELL
$4.94 - $9.43 $2,218 - $4,234
-449 Closed
0 $0
Q4 2020

May 19, 2021

BUY
$0.73 - $3.22 $327 - $1,445
449 New
449 $3,000
Q2 2020

Sep 07, 2021

SELL
$0.8 - $2.1 $359 - $942
-449 Closed
0 $0
Q1 2020

Sep 07, 2021

BUY
$1.0 - $6.05 $449 - $2,716
449 New
449 $1,000

About SECOND SIGHT MEDICAL PRODUCTS INC


  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.